Loading...
•
Sep 30, 2020
ResMed Q1 2021 Earnings Report
ResMed's first quarter results reflected solid performance with revenue growth and profitability improvements.
Key Takeaways
ResMed Inc. reported a 10% increase in revenue to $751.9 million and a 24% increase in non-GAAP operating profit for the first quarter of fiscal year 2021. The company continued to support the global COVID-19 pandemic response and saw sequential improvement in new patient volume in core markets.
Revenue increased by 10% year-over-year to $751.9 million.
Non-GAAP operating profit increased by 24% year-over-year.
GAAP diluted earnings per share were $1.22, while non-GAAP diluted earnings per share were $1.27.
The company supported the global COVID-19 pandemic response with ventilators, masks, and circuits.
Forward Guidance
No specific forward guidance was provided in the earnings report.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...